Medication must be part of any opioid addiction treatment plan because of how opioids "rewire" the brain, says NIH Director Francis Collins, adding that the NIH is funding development of longer-lasting addiction treatments as well as nonaddictive pain treatments. Collins also discusses NIH efforts to improve clinical trial efficiency and reduce drug prices, gene editing, attracting more women to the science community, and improving career environments for women in leadership roles.
NIH director discusses addiction treatments, clinical trials, women in science
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.